Back
CRISPR Therapeutics AG Stock Price Chart
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
44
CRSP
CRISPR Therapeutics AG
Last Price:
46.00
Seasonality Move:
12.87%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing slight buying pressure.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.88 | Sell |
| 20-day SMA: | 49.26 | Sell |
| 50-day SMA: | 47.94 | Sell |
| 200-day SMA: | 57.34 | Sell |
| 8-day EMA: | 48.22 | Sell |
| 20-day EMA: | 48.73 | Sell |
| 50-day EMA: | 48.73 | Sell |
| 200-day EMA: | 53.39 | Sell |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 45.23 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.99 - 51.07) | Sell |
| Bollinger Bands (100): | (45.67 - 53.91) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
- CRISPR Therapeutics AG share price is 47.26 while CRSP 8-day simple moving average is 48.88, which is a Sell signal.
- The stock price of CRSP is 47.26 while CRISPR Therapeutics AG 20-day SMA is 49.26, which makes it a Sell.
- CRISPR Therapeutics AG 50-day simple moving average is 47.94 while CRSP share price is 47.26, making it a Sell technically.
- CRSP stock price is 47.26 and CRISPR Therapeutics AG 200-day simple moving average is 57.34, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
44
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a Sell
The current CRISPR Therapeutics AG [CRSP] share price is $47.26. The Score for CRSP is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
4.03B
Price in USD:
47.26
Share Volume:
1.94M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
91.10
52-Week Low:
43.42
Sell
44
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?
The CRISPR Therapeutics AG stock price is 47.26 USD today. -
Will CRSP stock go up or go down?
CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators -
Is CRISPR Therapeutics AG overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
- CRISPR Therapeutics AG share price is 47.26 while CRSP 8-day exponential moving average is 48.22, which is a Sell signal.
- The stock price of CRSP is 47.26 while CRISPR Therapeutics AG 20-day EMA is 48.73, which makes it a Sell.
- CRISPR Therapeutics AG 50-day exponential moving average is 48.73 while CRSP share price is 47.26, making it a Sell technically.
- CRSP stock price is 47.26 and CRISPR Therapeutics AG 200-day simple moving average is 53.39, creating a Sell signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.19 per share, and an increase next year of $0.13 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
- CRSP Moving Average Covergence Divergence (MACD) indicator is -0.07, suggesting CRISPR Therapeutics AG is a Sell
- CRISPR Therapeutics AG Relative Strength Index (RSI) is 45.23, which suggest CRISPR Therapeutics AG is oversold
- The Bollinger Bands (25) for CRISPR Therapeutics AG is (46.99 - 51.07), which suggest CRISPR Therapeutics AG is a Sell
- The Bollinger Bands (100) for CRISPR Therapeutics AG is (45.67 - 53.91), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.